Editas Medicine, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 5 | -$1.85 | $0.18 | -$0.63 |
| Q2 2024 | 5 | -$2.08 | $0.20 | -$0.70 |
| Q3 2024 | 4 | -$2.21 | $0.21 | -$0.75 |
| Q4 2024 | 11 | -$0.81 | $0.37 | -$0.33 |
| Q1 2025 | 5 | -$0.73 | -$0.50 | -$0.67 |
| Q2 2025 | 4 | -$1.95 | $0.18 | -$0.66 |
| Q3 2025 | 4 | -$1.86 | $0.18 | -$0.63 |
| Q4 2025 | 4 | -$1.85 | $0.18 | -$0.63 |
| Q1 2026 | 3 | -$1.46 | $0.14 | -$0.49 |
| Q2 2026 | 3 | -$1.28 | $0.12 | -$0.43 |
| Q3 2026 | 3 | -$1.28 | $0.12 | -$0.43 |
| Q4 2026 | 3 | -$1.28 | $0.12 | -$0.43 |
Editas Medicine, Inc. Earnings Date And Information
Editas Medicine, Inc. last posted its earnings results on Monday, November 4th, 2024. The company reported $-0.75 earnings per share for the quarter, topping analysts' consensus estimates of $-0.76 by $0.01. The company had revenue of 61,000 for the quarter and had revenue of 78.12 M for the year. Editas Medicine, Inc. has generated $-2 earnings per share over the last year ($-2.02 diluted earnings per share) and currently has a price-to-earnings ratio of -0.93. Editas Medicine, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based on prior year's report dates.
Editas Medicine, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/04/2024 | Q3 2024 | -$0.76 | -$0.75 | 0.01 | $3.93 M | $61,000 |
| 08/07/2024 | Q2 2024 | -$0.69 | -$0.82 | -0.13 | $4.78 M | $513,000 |
| 05/08/2024 | Q1 2024 | -$0.63 | -$0.76 | -0.13 | $1.14 M | |
| 02/28/2024 | Q4 2023 | -$0.52 | -$0.23 | 0.29 | $60.05 M | |
| 11/03/2023 | Q3 2023 | -$0.64 | -$0.55 | 0.09 | $3.70 M | $5.34 M |
| 08/02/2023 | Q2 2023 | -$0.76 | -$0.56 | 0.2 | $4.17 M | $2.89 M |
| 05/05/2023 | Q1 2023 | -$0.79 | -$0.66 | 0.13 | $9.85 M | |
| 02/22/2023 | Q4 2022 | -$0.84 | -$0.80 | 0.04 | $6.54 M | |
| 11/02/2022 | Q3 2022 | -$0.87 | -$0.78 | 0.09 | $4.39 M | $42,000 |
| 08/03/2022 | Q2 2022 | -$0.84 | -$0.77 | 0.07 | $4.29 M | $6.36 M |
| 05/04/2022 | Q1 2022 | -$0.81 | -$0.74 | 0.07 | $6.77 M | |
| 02/24/2022 | Q4 2021 | -$0.78 | -$0.61 | 0.17 | $12.47 M | |
| 11/09/2021 | Q3 2021 | -$0.57 | $4.74 M | $6.20 M | ||
| 08/05/2021 | Q2 2021 | -$0.81 | $6.03 M | $379,000 | ||
| 05/06/2021 | Q1 2021 | -$0.86 | $6.50 M | |||
| 02/26/2021 | Q4 2020 | -$1.01 | $11.42 M | |||
| 11/06/2020 | Q3 2020 | $0.13 | $6.36 M | $62.84 M | ||
| 08/07/2020 | Q2 2020 | -$0.43 | $6.34 M | $10.75 M | ||
| 05/08/2020 | Q1 2020 | -$0.69 | $5.72 M | |||
| 02/26/2020 | Q4 2019 | $0.35 | -$0.74 | -1.09 | $12.28 M |
Editas Medicine, Inc. Earnings: Frequently Asked Questions
-
When is Editas Medicine, Inc.'s earnings date?
Editas Medicine, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based off last year's report dates.
-
Did Editas Medicine, Inc. beat their earnings estimates last quarter?
In the previous quarter, Editas Medicine, Inc. (:EDIT) reported $-0.75 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.76 by $0.01.
-
How can I listen to Editas Medicine, Inc.'s earnings conference call?
The conference call for Editas Medicine, Inc.'s latest earnings report can be listened to online.
-
How can I read Editas Medicine, Inc.'s conference call transcript?
The conference call transcript for Editas Medicine, Inc.'s latest earnings report can be read online.
-
How much revenue does Editas Medicine, Inc. generate each year?
Editas Medicine, Inc. (:EDIT) has a recorded annual revenue of $78.12 M.
-
How much profit does Editas Medicine, Inc. generate each year?
Editas Medicine, Inc. (:EDIT) has a recorded net income of $78.12 M. Editas Medicine, Inc. has generated $-2.02 earnings per share over the last four quarters.
-
What is Editas Medicine, Inc.'s price-to-earnings ratio?
Editas Medicine, Inc. (:EDIT) has a price-to-earnings ratio of -0.93 and price/earnings-to-growth ratio is 0.11.
